Pharmaceutical Technology

JUNE 21, 2023

Life sciences venture capital firm Flagship Pioneering has unveiled Empress Therapeutics, a small molecule drug development startup. This will support development of its proprietary Chemilogics platform and drug discovery pipeline. So far, Empress claims to have generated 15 drug leads across multiple indications.

Compounding 52

Compounding Communication Immunity Immunization 52

Pharmaceutical Technology

APRIL 24, 2023

With early nanoparticle studies, researchers often found the human body’s innate immune response to drugs and the short-lasting effects of drugs challenging, as they can also reduce a drug’s efficacy. GlobalData predicts that Comirnaty’s sales will increase by more than 20% between 2024 and 2027.

Vaccines 59

Vaccines Immunity Immunization Medical Schools 59

pharmaphorum

JANUARY 10, 2023

Astellas has licensed rights to a drug developed by Selecta Biosciences that could make more patients eligible for treatment with its gene therapy for inherited neuromuscular disorder Pompe disease. There has been no update from Astellas since the clinical hold was imposed last June.

Immunity 119

Immunity Immunization Drug Development 119

European Pharmaceutical Review

MARCH 4, 2024

Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5 percent through 2027. Anna has a medical degree and a postgraduate degree in healthcare management and is an expert in all stages of drug development.

Vaccines 98

Vaccines Immunity Immunization Compounding 98